Tikun Olam-Cannbit Pharmaceuticals Ltd

ILA 137,500As of Sun 8 Nov 2026, 12:00 UTC
TASE:TKUN-MHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR (52.26%)
Div yield —
ROE —
Pharmaceutical Preparations
Beta (5Y) 0.23
PE TTM —
TSR TTM (92.03%)
Mkt cap ILS 2.336M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 162,201
17.96%
(52.97%)
Hold 8|4|5|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per shareILS
1,584
1,569
1,697
1,719
16.34%
9.46%
21.84%
11.95%
RevenueILS M
0.246
0.258
0.273
0.283
5.43%
12.92%
16.81%
20.51%
Peers (US$0.730M)
Cap (US$)
PE
5.881M
—
Capital
TTM
5Y
10Y
Leveragex
0.356
(0.076)
(0.082)
EBIT/Intx
0.061
0.839
0.972
Own earn%
100.01
(25.87)
(14.84)
Sh yield%
42.20
29.22
32.19
Owners
Insiders/Inst%
11.31
38.55
Short interest%
5.50
SBC / revenue%
3.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
15–20
$1 testx
—
Incr. ROIC%
1